(Q36852626)

English

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine

scientific article published on June 2013

Statements

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
Herve J Fleury
Claudia A Hawkins
Weerawat Manosuthi
Laurent Belec
Sherri Burda
Alaka K Deshpande
Ziad El-Katib
Jean-Chrysostome Gody
Nicolas A Margot
Sandrine Moussa
Phillipe N Nyambi
Rob Schuurman
Sunee Sirivichayakul
Michael R Jordan
1 June 2013
207 Suppl 2
S70-7

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit